Compare LAKE & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAKE | VANI |
|---|---|---|
| Founded | 1982 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.2M | 95.8M |
| IPO Year | 2013 | 2014 |
| Metric | LAKE | VANI |
|---|---|---|
| Price | $8.76 | $1.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $17.33 | $4.00 |
| AVG Volume (30 Days) | 78.8K | ★ 190.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | N/A | ★ 14.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $167,211,000.00 | $4,000,000.00 |
| Revenue This Year | $19.87 | N/A |
| Revenue Next Year | $8.32 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2554.14 | N/A |
| 52 Week Low | $7.77 | $0.91 |
| 52 Week High | $21.19 | $1.92 |
| Indicator | LAKE | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 38.58 | 32.87 |
| Support Level | $8.70 | N/A |
| Resistance Level | $9.67 | $1.27 |
| Average True Range (ATR) | 0.34 | 0.05 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 38.62 | 14.29 |
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.